Ibandronate study [Design Issues]

posted by MGR  – India, 2008-07-08 15:06 (6566 d 00:03 ago) – Posting: # 2004
Views: 4,776

Dear Dr.Sudhee,

The following link may help you,

http://www.fda.gov/cder/foi/nda/2003/21-455_Boniva.htm

In the above link you can find the documents (especially in clinical Biopharmaceutics) contains the Reference drug conducted studies, intrasubject CV, etc...

the following link are the recommendations from the USFDA to conduct the study:
http://www.fda.gov/cder/guidance/bioequivalence/recommendations/Ibandronate_tab_21455_RC11-06.pdf


We have conducted the study as a pilot study with 18 subjects.

Regards,
MGR

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
314 visitors (0 registered, 314 guests [including 21 identified bots]).
Forum time: 15:09 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5